# Cellares funding rounds and investors

As of 14 Oct 2026, Cellares has raised $257M across 1 verified round on record; latest: $257 million Series D led by BlackRock and Eclipse Capital, announced 28 Jan 2026.

Cellares specializes in advanced manufacturing technologies for cell therapy, targeting biopharmaceutical companies and healthcare providers.

Website: https://cellares.com  
Headquarters: South San Francisco, CA  
Page: https://fireround.dev/companies/cellares.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-01-28 | Series D | $257 million | BlackRock, Eclipse Capital | Baillie Gifford, DC Global Ventures, DFJ Growth, Duquesne Family Office, EDBI (Singapore), Gates Frontier, Intuitive Ventures, T. Rowe Price, Willett Advisors | [cellares.com](https://www.cellares.com/news/cellares-raises-257-million-series-d-led-by-blackrock-and-eclipse-to-industrialize-global-cell-therapy-manufacturing-with-breakthrough-automation) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.